Implements evidence-based glucose control (140-180 mg/dL target per NICE-SUGAR) in ICU patients with insulin infusion titration, hypoglycemia risk stratification, and continuous glucose monitoring integration.
BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).
BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.
Enter the values for the patient or scenario you are assessing. Implements evidence-based glucose control (140-180 mg/dL target per NICE-SUGAR) in ICU patients with insulin infusion titration, hypoglycemia risk stratification, and continuous glucose monitoring integration. Use the icu glucose control result to inform your clinical assessment.